ArticleProceedings of the National Academy of Sciences of the United States of America2022
A call for an independent inquiry into the origin of the SARS-CoV-2 virus.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Clues to Long COVID Linked to Virulence and Infectivity Found in Shell Proteins.Advances in respiratory medicine · 2026Review
- Beyond Processing: Furin as a Central Hub in Viral Pathogenesis and Genetic Susceptibility.Biomolecules · 2025Review
- Biosafety, biosecurity, and bioethics.Monash bioethics review · 2024Review
- Biophysical evolution of the receptor-binding domains of SARS-CoVs.Biophysical journal · 2023Article
- The Question of the Origins of COVID-19 and the Ends of Science.Journal of bioethical inquiry · 2023Article
- Viral infections at the animal-human interface-Learning lessons from the SARS-CoV-2 pandemic.Microbial biotechnology · 2023Article
- Article
- SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19.EMBO reports · 2023Article
- History of advances in genetic engineering of viruses before COVID-19 pandemic.Surgical neurology international · 2023Article
- Recombination between coronaviruses and synthetic RNAs and biorisk implications motivated by a SARS-CoV-2 FCS origin controversy.Frontiers in bioengineering and biotechnology · 2023Article
- The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation.Science advances · 2022Article
- The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Reply to Garry: The origin of SARS-CoV-2 remains unresolved.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Comparing and contrasting two United Nations Environment Programme reports on COVID-19.Science in One Health · 2022Article
- Article
- SARS-CoV-2 furin cleavage site was not engineered.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.